nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—AR—penis—type 1 diabetes mellitus	0.058	0.229	CbGeAlD
Mifepristone—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.0282	0.0476	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.0238	0.0403	CcSEcCtD
Mifepristone—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.023	0.0389	CcSEcCtD
Mifepristone—Breast disorder—Ramipril—type 1 diabetes mellitus	0.0203	0.0343	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.0202	0.0342	CcSEcCtD
Mifepristone—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.0202	0.0342	CcSEcCtD
Mifepristone—NR3C1—nerve—type 1 diabetes mellitus	0.0193	0.0762	CbGeAlD
Mifepristone—CYP3A7-CYP3A51P—nephron tubule—type 1 diabetes mellitus	0.0183	0.0724	CbGeAlD
Mifepristone—Sinusitis—Ramipril—type 1 diabetes mellitus	0.0163	0.0275	CcSEcCtD
Mifepristone—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.0153	0.0259	CcSEcCtD
Mifepristone—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.0153	0.0258	CcSEcCtD
Mifepristone—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.014	0.0237	CcSEcCtD
Mifepristone—Mental disorder—Ramipril—type 1 diabetes mellitus	0.0136	0.023	CcSEcCtD
Mifepristone—Malnutrition—Ramipril—type 1 diabetes mellitus	0.0135	0.0229	CcSEcCtD
Mifepristone—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.013	0.022	CcSEcCtD
Mifepristone—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.0126	0.0212	CcSEcCtD
Mifepristone—Angioedema—Ramipril—type 1 diabetes mellitus	0.0124	0.0209	CcSEcCtD
Mifepristone—Malaise—Ramipril—type 1 diabetes mellitus	0.0122	0.0206	CcSEcCtD
Mifepristone—PGR—cardiovascular system—type 1 diabetes mellitus	0.0117	0.0463	CbGeAlD
Mifepristone—Myalgia—Ramipril—type 1 diabetes mellitus	0.0115	0.0195	CcSEcCtD
Mifepristone—Arthralgia—Ramipril—type 1 diabetes mellitus	0.0115	0.0195	CcSEcCtD
Mifepristone—Anxiety—Ramipril—type 1 diabetes mellitus	0.0115	0.0194	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.0114	0.0194	CcSEcCtD
Mifepristone—Discomfort—Ramipril—type 1 diabetes mellitus	0.0114	0.0193	CcSEcCtD
Mifepristone—Dry mouth—Ramipril—type 1 diabetes mellitus	0.0113	0.0191	CcSEcCtD
Mifepristone—Oedema—Ramipril—type 1 diabetes mellitus	0.0111	0.0187	CcSEcCtD
Mifepristone—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.0108	0.0183	CcSEcCtD
Mifepristone—Skin disorder—Ramipril—type 1 diabetes mellitus	0.0107	0.0181	CcSEcCtD
Mifepristone—Anorexia—Ramipril—type 1 diabetes mellitus	0.0105	0.0178	CcSEcCtD
Mifepristone—Hypotension—Ramipril—type 1 diabetes mellitus	0.0103	0.0175	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.0101	0.017	CcSEcCtD
Mifepristone—Insomnia—Ramipril—type 1 diabetes mellitus	0.00999	0.0169	CcSEcCtD
Mifepristone—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00985	0.0167	CcSEcCtD
Mifepristone—PGR—lymphoid tissue—type 1 diabetes mellitus	0.00984	0.0389	CbGeAlD
Mifepristone—Somnolence—Ramipril—type 1 diabetes mellitus	0.00982	0.0166	CcSEcCtD
Mifepristone—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00961	0.0162	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00954	0.0161	CcSEcCtD
Mifepristone—Fatigue—Ramipril—type 1 diabetes mellitus	0.00953	0.0161	CcSEcCtD
Mifepristone—Constipation—Ramipril—type 1 diabetes mellitus	0.00945	0.016	CcSEcCtD
Mifepristone—CYP3A5—islet of Langerhans—type 1 diabetes mellitus	0.00942	0.0372	CbGeAlD
Mifepristone—NR3C1—islet of Langerhans—type 1 diabetes mellitus	0.00934	0.0369	CbGeAlD
Mifepristone—AR—cardiovascular system—type 1 diabetes mellitus	0.00933	0.0369	CbGeAlD
Mifepristone—AR—kidney—type 1 diabetes mellitus	0.00913	0.0361	CbGeAlD
Mifepristone—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00911	0.0154	CcSEcCtD
Mifepristone—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00904	0.0153	CcSEcCtD
Mifepristone—Urticaria—Ramipril—type 1 diabetes mellitus	0.00878	0.0148	CcSEcCtD
Mifepristone—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00874	0.0148	CcSEcCtD
Mifepristone—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00874	0.0148	CcSEcCtD
Mifepristone—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00814	0.0138	CcSEcCtD
Mifepristone—Asthenia—Ramipril—type 1 diabetes mellitus	0.00793	0.0134	CcSEcCtD
Mifepristone—AR—lymphoid tissue—type 1 diabetes mellitus	0.00784	0.031	CbGeAlD
Mifepristone—Pruritus—Ramipril—type 1 diabetes mellitus	0.00782	0.0132	CcSEcCtD
Mifepristone—CYP3A5—nephron tubule—type 1 diabetes mellitus	0.00758	0.0299	CbGeAlD
Mifepristone—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00756	0.0128	CcSEcCtD
Mifepristone—NR3C1—nephron tubule—type 1 diabetes mellitus	0.00752	0.0297	CbGeAlD
Mifepristone—Dizziness—Ramipril—type 1 diabetes mellitus	0.00731	0.0124	CcSEcCtD
Mifepristone—Vomiting—Ramipril—type 1 diabetes mellitus	0.00703	0.0119	CcSEcCtD
Mifepristone—Rash—Ramipril—type 1 diabetes mellitus	0.00697	0.0118	CcSEcCtD
Mifepristone—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00696	0.0118	CcSEcCtD
Mifepristone—Headache—Ramipril—type 1 diabetes mellitus	0.00692	0.0117	CcSEcCtD
Mifepristone—NR3C1—cardiovascular system—type 1 diabetes mellitus	0.00676	0.0267	CbGeAlD
Mifepristone—CYP3A5—kidney—type 1 diabetes mellitus	0.00666	0.0263	CbGeAlD
Mifepristone—CYP3A5—pancreas—type 1 diabetes mellitus	0.00662	0.0261	CbGeAlD
Mifepristone—NR3C1—kidney—type 1 diabetes mellitus	0.00661	0.0261	CbGeAlD
Mifepristone—NR3C1—pancreas—type 1 diabetes mellitus	0.00657	0.0259	CbGeAlD
Mifepristone—Nausea—Ramipril—type 1 diabetes mellitus	0.00656	0.0111	CcSEcCtD
Mifepristone—NR3C1—lymphoid tissue—type 1 diabetes mellitus	0.00568	0.0224	CbGeAlD
Mifepristone—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.005	0.0198	CbGeAlD
Mifepristone—CYP3A4—kidney—type 1 diabetes mellitus	0.005	0.0198	CbGeAlD
Mifepristone—CYP2D6—kidney—type 1 diabetes mellitus	0.00492	0.0194	CbGeAlD
Mifepristone—ABCB1—retina—type 1 diabetes mellitus	0.00428	0.0169	CbGeAlD
Mifepristone—ABCB1—nephron tubule—type 1 diabetes mellitus	0.00403	0.0159	CbGeAlD
Mifepristone—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.00362	0.0143	CbGeAlD
Mifepristone—ABCB1—kidney—type 1 diabetes mellitus	0.00354	0.014	CbGeAlD
Mifepristone—ABCB1—pancreas—type 1 diabetes mellitus	0.00352	0.0139	CbGeAlD
Mifepristone—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.00304	0.012	CbGeAlD
Mifepristone—NR3C1—AP-1 transcription factor network—IL10—type 1 diabetes mellitus	0.00101	0.0065	CbGpPWpGaD
Mifepristone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.000992	0.00639	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.000987	0.00636	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	0.000982	0.00633	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—IL4—type 1 diabetes mellitus	0.000981	0.00632	CbGpPWpGaD
Mifepristone—NR3C1—Transcription factor regulation in adipogenesis—TNF—type 1 diabetes mellitus	0.000969	0.00624	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—CD86—type 1 diabetes mellitus	0.000957	0.00616	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.000952	0.00613	CbGpPWpGaD
Mifepristone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—type 1 diabetes mellitus	0.000942	0.00607	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—type 1 diabetes mellitus	0.000933	0.00601	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—type 1 diabetes mellitus	0.000922	0.00594	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—FOXP3—type 1 diabetes mellitus	0.000919	0.00592	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—type 1 diabetes mellitus	0.000897	0.00578	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—HLA-A—type 1 diabetes mellitus	0.000889	0.00573	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—IL4—type 1 diabetes mellitus	0.000864	0.00557	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—ERBB3—type 1 diabetes mellitus	0.000863	0.00556	CbGpPWpGaD
Mifepristone—AR—Notch-mediated HES/HEY network—STAT3—type 1 diabetes mellitus	0.000804	0.00518	CbGpPWpGaD
Mifepristone—NR3C1—Transcription factor regulation in adipogenesis—IL6—type 1 diabetes mellitus	0.000782	0.00504	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—type 1 diabetes mellitus	0.000762	0.00491	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000759	0.00489	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	0.000745	0.0048	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—type 1 diabetes mellitus	0.000708	0.00456	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.0007	0.00451	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—CD80—type 1 diabetes mellitus	0.000698	0.0045	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—E2F1—type 1 diabetes mellitus	0.000695	0.00448	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—HLA-DPB1—type 1 diabetes mellitus	0.000667	0.0043	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—HLA-E—type 1 diabetes mellitus	0.000656	0.00423	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CTLA4—type 1 diabetes mellitus	0.000632	0.00407	CbGpPWpGaD
Mifepristone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.000611	0.00394	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000598	0.00386	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—E2F1—type 1 diabetes mellitus	0.000595	0.00383	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—IFNG—type 1 diabetes mellitus	0.000593	0.00382	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—TYK2—type 1 diabetes mellitus	0.000589	0.0038	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.000576	0.00371	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CDK4—type 1 diabetes mellitus	0.000567	0.00365	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—HLA-DQA1—type 1 diabetes mellitus	0.000557	0.00359	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.000553	0.00357	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000549	0.00354	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.000531	0.00342	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—IL2—type 1 diabetes mellitus	0.000527	0.0034	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—type 1 diabetes mellitus	0.000522	0.00337	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—HLA-DQB1—type 1 diabetes mellitus	0.000521	0.00336	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000519	0.00334	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—IL1R1—type 1 diabetes mellitus	0.000515	0.00332	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CD86—type 1 diabetes mellitus	0.000501	0.00323	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—ZFP36L1—type 1 diabetes mellitus	0.000499	0.00322	CbGpPWpGaD
Mifepristone—CYP3A4—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.000494	0.00319	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL10—type 1 diabetes mellitus	0.000492	0.00317	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CD40LG—type 1 diabetes mellitus	0.000492	0.00317	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—STAT3—type 1 diabetes mellitus	0.000482	0.00311	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL4—type 1 diabetes mellitus	0.000478	0.00308	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00047	0.00303	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.00047	0.00303	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—HLA-B—type 1 diabetes mellitus	0.000468	0.00301	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—IL2—type 1 diabetes mellitus	0.000464	0.00299	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—FASLG—type 1 diabetes mellitus	0.000457	0.00295	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—EGFR—type 1 diabetes mellitus	0.000438	0.00282	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL2RA—type 1 diabetes mellitus	0.000438	0.00282	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—NOS2—type 1 diabetes mellitus	0.000435	0.00281	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—HLA-A—type 1 diabetes mellitus	0.000433	0.00279	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—INS—type 1 diabetes mellitus	0.000432	0.00278	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—IGF1—type 1 diabetes mellitus	0.000418	0.00269	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.000405	0.00261	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—VDR—type 1 diabetes mellitus	0.000399	0.00257	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000397	0.00256	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—HLA-DRB1—type 1 diabetes mellitus	0.000396	0.00255	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.00039	0.00252	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.000388	0.0025	CbGpPWpGaD
Mifepristone—AR—Gene Expression—ZFP36L1—type 1 diabetes mellitus	0.00038	0.00245	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000376	0.00242	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—EGFR—type 1 diabetes mellitus	0.000375	0.00242	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.000367	0.00237	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.000366	0.00236	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CD80—type 1 diabetes mellitus	0.000366	0.00236	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000365	0.00236	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000362	0.00234	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.00034	0.00219	CbGpPWpGaD
Mifepristone—ABCC1—Disease—G6PC2—type 1 diabetes mellitus	0.000335	0.00216	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000312	0.00201	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—IL6—type 1 diabetes mellitus	0.00031	0.002	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—VDR—type 1 diabetes mellitus	0.000304	0.00196	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—HBA2—type 1 diabetes mellitus	0.000298	0.00192	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IFNG—type 1 diabetes mellitus	0.000289	0.00186	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ZFP36L1—type 1 diabetes mellitus	0.000289	0.00186	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—IL6—type 1 diabetes mellitus	0.000288	0.00186	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000287	0.00185	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000285	0.00183	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—G6PC2—type 1 diabetes mellitus	0.00028	0.00181	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.000279	0.0018	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.000278	0.00179	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 1 diabetes mellitus	0.000273	0.00176	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—STAT3—type 1 diabetes mellitus	0.00027	0.00174	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000266	0.00172	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—HBA2—type 1 diabetes mellitus	0.00026	0.00168	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL1B—type 1 diabetes mellitus	0.000258	0.00166	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CASP3—type 1 diabetes mellitus	0.000257	0.00166	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL2—type 1 diabetes mellitus	0.000257	0.00166	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000255	0.00164	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000249	0.0016	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000247	0.00159	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000246	0.00159	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000246	0.00159	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—G6PC2—type 1 diabetes mellitus	0.000244	0.00158	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000243	0.00157	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000238	0.00153	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.000235	0.00151	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—TNF—type 1 diabetes mellitus	0.000234	0.00151	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000231	0.00149	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—VDR—type 1 diabetes mellitus	0.000231	0.00149	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000227	0.00146	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.000226	0.00145	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.000215	0.00139	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ABCC8—type 1 diabetes mellitus	0.000212	0.00137	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000208	0.00134	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SLC11A1—type 1 diabetes mellitus	0.000203	0.00131	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000202	0.0013	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000195	0.00126	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000194	0.00125	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000194	0.00125	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ITPR3—type 1 diabetes mellitus	0.000194	0.00125	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—VDR—type 1 diabetes mellitus	0.000192	0.00124	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000192	0.00124	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.000191	0.00123	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000189	0.00122	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—IL6—type 1 diabetes mellitus	0.000189	0.00122	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—HBA2—type 1 diabetes mellitus	0.000188	0.00121	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—TNF—type 1 diabetes mellitus	0.000187	0.00121	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IAPP—type 1 diabetes mellitus	0.000181	0.00117	CbGpPWpGaD
Mifepristone—ABCC1—Disease—APOC3—type 1 diabetes mellitus	0.000181	0.00117	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—G6PC2—type 1 diabetes mellitus	0.000177	0.00114	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000174	0.00112	CbGpPWpGaD
Mifepristone—ABCC1—Disease—B2M—type 1 diabetes mellitus	0.000174	0.00112	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000172	0.00111	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SST—type 1 diabetes mellitus	0.000171	0.0011	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00017	0.00109	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000168	0.00108	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.000165	0.00106	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.000163	0.00105	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000162	0.00104	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ABCC8—type 1 diabetes mellitus	0.000153	0.000987	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—HBA1—type 1 diabetes mellitus	0.000153	0.000983	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000152	0.00098	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—APOC3—type 1 diabetes mellitus	0.000152	0.000977	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000149	0.00096	CbGpPWpGaD
Mifepristone—AR—Gene Expression—VDR—type 1 diabetes mellitus	0.000146	0.000943	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000146	0.000943	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOS1—type 1 diabetes mellitus	0.000146	0.000939	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000142	0.000916	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	0.000142	0.000914	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000142	0.000913	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ITPR3—type 1 diabetes mellitus	0.000141	0.000911	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000137	0.000885	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PRKCQ—type 1 diabetes mellitus	0.000136	0.000879	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	0.000134	0.000861	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000133	0.000859	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—HBA1—type 1 diabetes mellitus	0.000133	0.000858	CbGpPWpGaD
Mifepristone—ABCC1—Disease—VAV1—type 1 diabetes mellitus	0.000132	0.000854	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—APOC3—type 1 diabetes mellitus	0.000132	0.000852	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000131	0.000841	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTT1—type 1 diabetes mellitus	0.00013	0.000837	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000129	0.000829	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000127	0.000818	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	0.000126	0.00081	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000124	0.000799	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000121	0.00078	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GCG—type 1 diabetes mellitus	0.000119	0.000765	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000118	0.000758	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000116	0.000745	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD86—type 1 diabetes mellitus	0.000115	0.000744	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000112	0.00072	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—VDR—type 1 diabetes mellitus	0.000111	0.000716	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.00011	0.000708	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	0.000109	0.000702	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000108	0.000698	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ERBB3—type 1 diabetes mellitus	0.000104	0.000671	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GCG—type 1 diabetes mellitus	0.000103	0.000667	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CCR5—type 1 diabetes mellitus	0.000102	0.00066	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ITPR3—type 1 diabetes mellitus	0.000102	0.000659	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CAT—type 1 diabetes mellitus	0.0001	0.000647	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HLA-A—type 1 diabetes mellitus	9.98e-05	0.000643	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	9.7e-05	0.000625	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—HBA1—type 1 diabetes mellitus	9.62e-05	0.00062	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—APOC3—type 1 diabetes mellitus	9.56e-05	0.000616	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTT1—type 1 diabetes mellitus	9.39e-05	0.000605	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	9.24e-05	0.000595	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	9.14e-05	0.000589	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CD80—type 1 diabetes mellitus	9.04e-05	0.000583	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CAT—type 1 diabetes mellitus	8.76e-05	0.000565	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	8.74e-05	0.000563	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOS2—type 1 diabetes mellitus	8.68e-05	0.00056	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	8.61e-05	0.000555	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—INS—type 1 diabetes mellitus	8.54e-05	0.00055	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD80—type 1 diabetes mellitus	8.43e-05	0.000543	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.26e-05	0.000532	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	8.21e-05	0.000529	CbGpPWpGaD
Mifepristone—ABCC1—Disease—INS—type 1 diabetes mellitus	7.96e-05	0.000513	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	7.71e-05	0.000497	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.63e-05	0.000492	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.49e-05	0.000483	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GCG—type 1 diabetes mellitus	7.48e-05	0.000482	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	7.27e-05	0.000468	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	7.26e-05	0.000468	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	7.21e-05	0.000465	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	7.12e-05	0.000459	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TYK2—type 1 diabetes mellitus	7.11e-05	0.000458	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	7.08e-05	0.000457	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOS3—type 1 diabetes mellitus	6.98e-05	0.00045	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	6.84e-05	0.000441	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	6.8e-05	0.000438	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	6.68e-05	0.00043	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—INS—type 1 diabetes mellitus	6.67e-05	0.00043	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD4—type 1 diabetes mellitus	6.43e-05	0.000415	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.36e-05	0.00041	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL2—type 1 diabetes mellitus	6.35e-05	0.000409	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CAT—type 1 diabetes mellitus	6.33e-05	0.000408	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	6.21e-05	0.0004	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ALB—type 1 diabetes mellitus	6.11e-05	0.000394	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NOS3—type 1 diabetes mellitus	5.85e-05	0.000377	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—INS—type 1 diabetes mellitus	5.82e-05	0.000375	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	5.64e-05	0.000364	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	5.63e-05	0.000363	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.34e-05	0.000344	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ALB—type 1 diabetes mellitus	5.33e-05	0.000344	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	5.32e-05	0.000343	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NOS3—type 1 diabetes mellitus	5.1e-05	0.000329	CbGpPWpGaD
Mifepristone—ABCC1—Disease—STAT3—type 1 diabetes mellitus	4.98e-05	0.000321	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.86e-05	0.000313	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	4.78e-05	0.000308	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	4.75e-05	0.000306	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EGFR—type 1 diabetes mellitus	4.53e-05	0.000292	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	4.5e-05	0.00029	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	4.47e-05	0.000288	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	4.44e-05	0.000286	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	4.36e-05	0.000281	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—INS—type 1 diabetes mellitus	4.2e-05	0.000271	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ALB—type 1 diabetes mellitus	3.85e-05	0.000248	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL6—type 1 diabetes mellitus	3.73e-05	0.000241	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NOS3—type 1 diabetes mellitus	3.69e-05	0.000238	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL6—type 1 diabetes mellitus	3.48e-05	0.000224	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	3.48e-05	0.000224	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—INS—type 1 diabetes mellitus	3.17e-05	0.000204	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	2.99e-05	0.000193	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	2.94e-05	0.00019	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	2.91e-05	0.000187	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	2.78e-05	0.000179	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	2.74e-05	0.000177	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	2.62e-05	0.000169	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	1.95e-05	0.000126	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.79e-05	0.000115	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.71e-05	0.00011	CbGpPWpGaD
